Chronic lung disease (CLD) has been associated with chorioamnionitis and up
per respiratory tract colonisation with Ureaplasma urealyticum. The aim of
this review is to describe the increasing evidence that inflammation plays
a critical role in the early stages of CLD of the neonate. Ongoing lung dam
age in the premature infant may be caused by failure to downregulate and co
ntrol this inflammatory response. Tumour necrosis factor alpha (TNF-alpha),
interleukin-6 (IL-6) and IL-8 are important pro-inflammatory cytokines of
which IL-8 is an important chemotactic factor in the lung. Data suggest tha
t preterm newborns with lung inflammation may be unable to activate the ant
iinflammatory cytokine IL-10. Therefore, early post-natal anti-inflammatory
therapy could help in preventing development of CLD. Prophylactic dexameth
asone therapy cannot yet be recommended. There are a number of potential in
teractions between surfactant and cytokine effects on the preterm lung whic
h have not been evaluated. Surfactant protein A may be an important modulat
or of the immune response to lung injury. The role of high-frequency ventil
ation in the prevention of CLD still remains unclear.
Conclusion Many aspects of the pathogenesis of the inflammatory response in
the development of chronic lung disease remain to be elucidated. Further r
esearch to identify preterm infants at highest risk for the development of
this multifactorial and complex disease is needed.